Experimental cancer drug shows promise. The drug, geranylgeranyltransferase inhibitor GGTI-2418 suppresses a new defective PTEN cancer pathway, researchers have discovered. Source 8q.
Sponsored Links:
Post Date:Fri Apr 26 7:20:08 GMT 2024 / Post ID: #
Comment
Geranylgeranyltransferase Inhibitor Ggti-2418
In my opinion geranylgeranyltransferase inhibitor ggti2418 it should be investigated as soon as possible so that conceive to get the facts.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,